TrimMedium
DMRA has decisively broken below key support zones and all short-term EMAs, confirming continuation of the downtrend in a Stage 4 distribution phase. The primary Support Failure pattern grants medium-term permission for bearish engagement, but the oversold context and a recent relief bounce suggest short-term relief rallies may occur. Execution should be deferred until rallies into the 9-day or 20-day EMA offer clear rejection opportunities. A sustained reclaim of broken support or a close above the EMAs with follow-through would invalidate the current bearish stance.
- ↑TD Cowen upgraded DMRA to strong-buy with a $44 price target
- ↑Analyst revision trends are positive, hinting at upward EPS expectations
- ↓Negative earnings yield and weak profitability hamper valuation
Full analysis →